Impact of Dynamically Exposed Polarity on Permeability and Solubility of Chameleonic Drugs Beyond the Rule of 5

被引:152
作者
Sebastiano, Matteo Rossi [1 ]
Doak, Bradley C. [2 ]
Backlund, Maria [3 ]
Poongavanam, Vasanthanathan [1 ]
Over, Bjorn [4 ]
Ermondi, Giuseppe [5 ]
Caron, Giulia [5 ]
Matsson, Par [6 ]
Kihlberg, Jan [1 ]
机构
[1] Uppsala Univ, Dept Chem BMC, Box 576, SE-75123 Uppsala, Sweden
[2] Monash Univ, MIPS, Dept Med Chem, 381 Royal Parade, Parkville, Vic 3052, Australia
[3] Uppsala Univ, Uppsala Univ Drug Optimizat & Pharmaceut Profilin, Dept Pharm, BMC,Sci Life Lab, SE-75123 Uppsala, Sweden
[4] AstraZeneca R&D Gothenburg, Innovat Med & Early Dev Biotech Unit, Cardiovasc & Metab Dis, SE-43183 Molndal, Sweden
[5] Univ Turin, Dept Mol Biotechnol & Hlth Sci, Quarello 15, I-10135 Turin, Italy
[6] Uppsala Univ, BMC, Dept Pharm, Box 580, SE-75123 Uppsala, Sweden
关键词
PASSIVE MEMBRANE-PERMEABILITY; CELL-PERMEABILITY; CACO-2; MONOLAYERS; CYCLIC-PEPTIDES; PHYSICOCHEMICAL PROPERTIES; INTESTINAL-ABSORPTION; ORAL BIOAVAILABILITY; MOLECULAR-PROPERTIES; CLINICAL CANDIDATES; PROTEASE INHIBITORS;
D O I
10.1021/acs.jmedchem.8b00347
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Conformational flexibility has been proposed to significantly affect drug properties outside rule-of-5 (Ro5) chemical space. Here, we investigated the influence of dynamically exposed polarity on cell permeability and aqueous solubility for a structurally diverse set of drugs and clinical candidates far beyond the Ro5, all of which populated multiple distinct conformations as revealed by X-ray crystallography. Efflux-inhibited (passive) Caco-2 cell permeability correlated strongly with the compounds' minimum solvent-accessible 3D polar surface areas (PSA), whereas aqueous solubility depended less on the specific 3D conformation. Inspection of the crystal structures highlighted flexibly linked aromatic side chains and dynamically forming intramolecular hydrogen bonds as particularly effective in providing "chameleonic" properties that allow compounds to display both high cell permeability and aqueous solubility. These structural features, in combination with permeability predictions based on the correlation to solvent-accessible 3D PSA, should inspire drug design in the challenging chemical space far beyond the Ro5.
引用
收藏
页码:4189 / 4202
页数:14
相关论文
共 62 条
[41]   Polar molecular surface properties predict the intestinal absorption of drugs in humans [J].
Palm, K ;
Stenberg, P ;
Luthman, K ;
Artursson, P .
PHARMACEUTICAL RESEARCH, 1997, 14 (05) :568-571
[42]   Development of a Rule-Based Method for the Assessment of Protein Druggability [J].
Perola, Emanuele ;
Herman, Lee ;
Weiss, Jonathan .
JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2012, 52 (04) :1027-1038
[43]   Nonclassical Size Dependence of Permeation Defines Bounds for Passive Adsorption of Large Drug Molecules [J].
Pye, Cameron R. ;
Hewitt, William M. ;
Schwochert, Joshua ;
Haddad, Terra D. ;
Townsend, Chad E. ;
Etienne, Lyns ;
Lao, Yongtong ;
Limberakis, Chris ;
Furukawa, Akihiro ;
Mathiowetz, Alan M. ;
Price, David A. ;
Liras, Spiros ;
Lokey, R. Scott .
JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (05) :1665-1672
[44]   Predicting and Improving the Membrane Permeability of Peptidic Small Molecules [J].
Rafi, Salma B. ;
Hearn, Brian R. ;
Vedantham, Punitha ;
Jacobson, Matthew P. ;
Renslo, Adam R. .
JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (07) :3163-3169
[45]   The Druggable Genome: Evaluation of Drug Targets in Clinical Trials Suggests Major Shifts in Molecular Class and Indication [J].
Rask-Andersen, Mathias ;
Masuram, Surendar ;
Schioth, Helgi B. .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 54, 2014, 54 :9-26
[46]   Testing the conformational hypothesis of passive membrane permeability using synthetic cyclic peptide diastereomers [J].
Rezai, T ;
Yu, B ;
Millhauser, GL ;
Jacobson, MP ;
Lokey, RS .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2006, 128 (08) :2510-2511
[47]   Conformational flexibility, internal hydrogen bonding, and passive membrane permeability: Successful in silico prediction of the relative permeabilities of cyclic peptides [J].
Rezai, Taha ;
Bock, Jonathan E. ;
Zhou, Mai V. ;
Kalyanaraman, Chakrapani ;
Lokey, R. Scott ;
Jacobson, Matthew P. .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2006, 128 (43) :14073-14080
[48]   Characterisation of selected active agents regarding pKa values, solubility concentrations and pH profiles by SiriusT3 [J].
Schoenherr, D. ;
Wollatz, U. ;
Haznar-Garbacz, D. ;
Hanke, U. ;
Box, K. J. ;
Taylor, R. ;
Ruiz, R. ;
Beato, S. ;
Becker, D. ;
Weitschies, W. .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2015, 92 :155-170
[49]   Integrating Intramolecular Hydrogen Bonding (IMHB) Considerations in Drug Discovery Using ΔlogP As a Tool [J].
Shalaeva, Marina ;
Caron, Giulia ;
Abramov, Yuriy A. ;
O'Connell, Thomas N. ;
Plummer, Mark S. ;
Yalamanchi, Geeta ;
Farley, Kathleen A. ;
Goetz, Gilles H. ;
Philippe, Laurence ;
Shapiro, Michael J. .
JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (12) :4870-4879
[50]   Structural Artifacts in Protein-Ligand X-ray Structures: Implications for the Development of Docking Scoring Functions [J].
Sondergaard, Chresten R. ;
Garrett, Alison Elizabeth ;
Carstensen, Tommy ;
Pollastri, Gianluca ;
Nielsen, Jens Erik .
JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (18) :5673-5684